Bank of New York Mellon’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Sell |
|
|||||
|
2025
Q1 | $641K | Sell |
|
|||||
|
2024
Q4 | $1.1M | Sell |
|
|||||
|
2024
Q3 | $1.46M | Sell |
|
|||||
|
2024
Q2 | $2.33M | Buy |
|
|||||
|
2024
Q1 | $2.33M | Sell |
|
|||||
|
2023
Q4 | $2.13M | Buy |
|
|||||
|
2023
Q3 | $1.49M | Buy |
|
|||||
|
2023
Q2 | $2.19M | Buy |
|
|||||
|
2023
Q1 | $759K | Hold |
|
|||||
|
2022
Q4 | $601K | Sell |
|
|||||
|
2022
Q3 | $584K | Hold |
|
|||||
|
2022
Q2 | $584K | Buy |
|
|||||
|
2022
Q1 | $325K | Hold |
|
|||||
|
2021
Q4 | $115K | Sell |
|
|||||
|
2021
Q3 | $232K | Sell |
|
|||||
|
2021
Q2 | $377K | Sell |
|
|||||
|
2021
Q1 | $831K | Sell |
|
|||||
|
2020
Q4 | $1.27M | Sell |
|
|||||
|
2020
Q3 | $12.2M | Buy |
|
|||||
|
2020
Q2 | $14.2M | Buy |
|
|||||
|
2020
Q1 | $8.22M | Buy |
|
|||||
|
2019
Q4 | $7.78M | Buy |
|
|||||
|
2019
Q3 | $1.72M | Buy |
|
|||||
|
2019
Q2 | $2.72M | Buy |
|
|||||
|
2019
Q1 | $1.71M | Buy |
|
|||||
|
2018
Q4 | $831K | Buy |
|
|||||
|
2018
Q3 | $1.61M | Buy |
|
|||||
|
2018
Q2 | $1.64M | Buy |
|
|||||
|
2018
Q1 | $1.57M | Buy |
|
|||||
|
2017
Q4 | $1.29M | Buy |
|
|||||
|
2017
Q3 | $1.27M | Buy |
|
|||||
|
2017
Q2 | $477K | Buy |
|
|||||
|
2017
Q1 | $582K | Buy |
|
|||||
|
2016
Q4 | $485K | Buy |
|
|||||
|
2016
Q3 | $401K | Buy |
|
|||||
|
2016
Q2 | $365K | Buy |
|
|||||
|
2016
Q1 | $205K | Buy |
|
|||||
|
2015
Q4 | $307K | Buy |
|